NLS SwedenBIO Award

SwedenBIO awards this prize annually to a life science company that has excelled during the year and has contributed to societal benefits that underline the importance of a successful life science industry in Sweden. This year’s nominations for the SwedenBIO Award show the diversity that exists in Swedish life science. Swedish life science companies are […]

Calliditas Therapeutics received the award in recognition of its successful clinical development program of Nefecon, which culminated in the recent positive topline data readout of the Phase 3 NefIgArd trial. “This year’s winner has shown impressive professionalism and staying power with regards to the development of a completely new treatment for patients with IgA Nephropathy, […]

Biotage has received this year’s SwedenBIO Award for its commitment and contributions to the Swedish life science industry. Each year SwedenBIO, the national non-profit association for the life science industry in Sweden, highlights a company that has stood out when it comes to R&D, business development and growth, but also when it comes to contributions […]

Yesterday the 11th SwedenBIO Award was announced and the lucky winner was Oncopeptides. Oncopeptides received the award for its work in developing treatment against hematologic cancer. After several year of professional development work, Oncopeptides was able to present positive clinical phase II results with their drug candidate Ygalo in patients with Multiple Myeloma. Based on […]

Alligator Bioscience has received the SwedenBIO Award for ”exceptional achievements within the life science industry”. The 10th annual SwedenBIO Award was awarded at a price ceremony in Stockholm, Sweden, on Thursday evening. This year’s winner is Alligator Bioscience, whose pioneering research and great business acumen is a source of inspiration to companies throughout the Swedish […]

Pharmaceutical company Orexo has received this year’s SwedenBIO Award. The award ceremony took place on May 20 during SwedenBIO’s annual meeting. The award was received by Peder Edman, Orexo’s Chief Scientific Officer. The jury’s motivation: “Orexo has during the year succeded in getting Zubsolv both approved and launched in the United States. Swedish life science companies […]